SCHEMBL1713729

SCHEMBL1713729

O=CCCCCC(=O)CCCCC(=O)CCCCO

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.42
FFAR1 O14842 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
HIF1A Q16665 1/20 0.41
TSHR P16473 2/20 0.37
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CAMK2A Q9UQM7 1/20 0.35
FAAH O00519 4/20 0.34
GAA P10253 1/20 0.34
TRPV1 Q8NER1 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
SQLE Q14534 1/20 0.32
MAPT P10636 2/20 0.32
ABCC4 O15439 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1714397 1.00 GPR84 (0.42) GPR84FFAR1FFAR4HIF1ATSHR
SCHEMBL30497477 0.98 GPR84 (0.46) GPR84FFAR1FFAR4HIF1ATSHR
SCHEMBL12855872 0.98 GPR84 (0.46) GPR84FFAR1FFAR4HIF1ATSHR
SCHEMBL10406439 0.90 HIF1A (0.50) HIF1ATSHRFAAHTRPV1MAPT
SCHEMBL1714630 0.88 HIF1A (0.43) GPR84FFAR1FFAR4HIF1ATSHR
SCHEMBL25240636 0.87 TSHR (0.48) HIF1ATSHRFAAHTRPV1MAPT
SCHEMBL1714933 0.86 HIF1A (0.41) GPR84FFAR1FFAR4HIF1ATSHR
SCHEMBL12665061 0.85 HIF1A (0.45) HIF1ATSHRFAAHTRPV1MAPT
SCHEMBL196890 0.84
SCHEMBL9311929 0.83 HIF1A (0.43) HIF1ATSHRCAMK2AFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368604-B2 Method for the production of acylphosphine oxides BASF AKTIENGESELLSCHAFT (DE) 2008-05-06 US claimed
EP-1546163-B1 METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES BASF AG (DE) 2006-07-12 EP claimed
US-20060052636-A1 Method for the production of acylphosphine oxides BASF AKTIENGESELLSCHAFT (DE) 2006-03-09 US claimed
US-10577471-B2 Method for curing curable compositions BASF SE (DE) 2020-03-03 US disclosed
EP-3201261-B1 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2018-12-12 EP disclosed
US-20180148554-A9 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2018-05-31 US disclosed
US-9840635-B2 Binding agent systems CONSTRUCTION RESEARCH & TECHNOLOGY, GMBH (DE) 2017-12-12 US disclosed
US-20170306118-A1 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2017-10-26 US disclosed
EP-3066161-B1 COATINGS FOR USE AS ADHESIVE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2017-07-05 EP disclosed
US-20160280954-A1 NOVEL BINDING AGENT SYSTEMS SIKA TECHNOLOGY AG (CH) 2016-09-29 US disclosed
EP-1613638-B1 METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS BASF SE (DE) 2013-08-07 EP disclosed
US-20070167653-A1 Method for producing acylphosphine oxide solids BASF AKIENGESELLSCHAFT (DE) 2007-07-19 US disclosed
US-20070135556-A1 Coating materials containing alpha-(1'-hydroxyalkyl)acrylates BASF AKTIENGESELLSCHAFT (DE) 2007-06-14 US disclosed
EP-1546163-B1 METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES BASF AG (DE) 2006-07-12 EP disclosed
US-20060052636-A1 Method for the production of acylphosphine oxides BASF AKTIENGESELLSCHAFT (DE) 2006-03-09 US disclosed
EP-1613638-A2 METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS BASF AKTIENGESELLSCHAFT (DE) 2006-01-11 EP disclosed
US-20050222294-A1 Acyl- and bisacylphosphine derivatives IGM GROUP B.V. (NL) 2005-10-06 US disclosed
WO-2004094439-A2 METHOD FOR THE PRODUCTION OF ACYLPHOSPHINES BASF AKTIENGESELLSCHAFT (DE) 2004-11-04 WO disclosed
WO-2004087723-A2 METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS BASF AKTIENGESELLSCHAFT (DE) 2004-10-14 WO disclosed
US-20040116702-A1 Alkoxylated acyl-and bisacylphoshine derivatives BASF AKTIENGESELLSCHAFT (DE) 2004-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167653-A1 Method for producing acylphosphine oxide solids AGPAT5, PHOSPHO1, AGPS GPR84 4275/4885FFAR1 4449/4885FFAR4 4017/4885
US-20060052636-A1 Method for the production of acylphosphine oxides AGPAT5, PNPO, PHOSPHO1 GPR84 4187/4885FFAR1 4199/4885FFAR4 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.